SVS Stock Overview
Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products in Canada and internationally.
Solarvest BioEnergy Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||CA$0.11|
|52 Week High||CA$0.26|
|52 Week Low||CA$0.04|
|1 Month Change||0%|
|3 Month Change||22.22%|
|1 Year Change||0%|
|3 Year Change||-24.14%|
|5 Year Change||-45.00%|
|Change since IPO||-68.57%|
Recent News & Updates
|SVS||CA Personal Products||CA Market|
Return vs Industry: SVS exceeded the Canadian Personal Products industry which returned -51.1% over the past year.
Return vs Market: SVS matched the Canadian Market which returned 0.6% over the past year.
|SVS Average Weekly Movement||23.5%|
|Personal Products Industry Average Movement||15.4%|
|Market Average Movement||9.9%|
|10% most volatile stocks in CA Market||18.0%|
|10% least volatile stocks in CA Market||4.1%|
Stable Share Price: SVS is more volatile than 90% of Canadian stocks over the past 3 months, typically moving +/- 24% a week.
Volatility Over Time: SVS's weekly volatility (24%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products in Canada and internationally. It provides human nutrition products, including omega-3; clean energy production system enables for continuous hydrogen production; and pharmaceutical ingredients for human health comprising cannabinoids in algae and bone morphogenetic protein for the treatment of repairing bone fractures. Solarvest BioEnergy Inc. has a collaborative research and development agreement with FSD Pharma Inc. to develop algae-based pharmaceutical grade cannabinoids.
Solarvest BioEnergy Inc. Fundamentals Summary
|SVS fundamental statistics|
Is SVS overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|SVS income statement (TTM)|
|Cost of Revenue||CA$11.64k|
Last Reported Earnings
Jul 31, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.029|
|Net Profit Margin||-158,662.87%|
How did SVS perform over the long term?See historical performance and comparison